CRYO CELL INTERNATIONAL INC

Cryopreserves newborn cord blood and tissue stem cells for expectant families.

CCEL | NYSE

Overview

Corporate Details

ISIN(s):: US2288951088
LEI:
Country:: United States of America
Address:: 700 BROOKER CREEK BLVD, 34677 OLDSMAR
Website:: https://www.cryo-cell.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Cryo-Cell International, Inc., established in 1989, is the world's first private cord blood bank. The company provides premier cryopreservation services for umbilical cord blood and cord tissue stem cells. Its core business involves the collection, processing, and long-term cryogenic storage of these cells for exclusive family use. These stem cells can be used to treat numerous diseases and conditions, with ongoing research expanding their potential applications in regenerative medicine. Trusted by over 500,000 parents globally, Cryo-Cell utilizes advanced processing technologies and a proprietary five-chamber storage bag to ensure the long-term viability and multiple treatment opportunities from a single collection. The company's target market consists of expectant families seeking to preserve their newborn's stem cells for future health needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all CRYO CELL INTERNATIONAL INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CRYO CELL INTERNATIONAL INC

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for CRYO CELL INTERNATIONAL INC via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Public Policy Holding Company, Inc. Advisory group providing public policy, government relations, and strategic communications services.	United States of America	PPHC.L
Purple Biotech Ltd. Developing cancer therapies to overcome tumor immune evasion and drug resistance.	Israel	PPBT
Qualigen Therapeutics, Inc. A clinical-stage company developing innovative treatments for rare cancers in adults and children.	United States of America	QLGN
QUIA PHARMA AB Develops biobetters by enhancing approved drugs with a patented drug delivery platform.	Sweden	QUIA
QUINSTREET, INC AI-driven marketplaces connecting consumers to brands in finance & home services on a pay-per-result basis.	United States of America	QNST
Qurient Co., Ltd. Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.	South Korea	115180
Rafael Holdings, Inc. Invests in and develops novel therapeutics for cancer and rare diseases.	United States of America	RFL
RaQualia Pharma Inc. An R&D firm discovering novel small molecules for out-licensing to pharma partners.	Japan	4579
Recruit Holdings Co., Ltd. Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.	Japan	6098
RELMADA THERAPEUTICS, INC. A clinical-stage biotech developing novel therapies for CNS diseases and oncology.	United States of America	RLMD